CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813879991
- Phone
- 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $222,000
- in 2 filings, $222K under 10b5-1 plans
Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +3,805 | $4.30 | $16K | 162,649 |
| 2026-11-05 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −4,000 | $12.36 | $49K | 158,649 |
| 2026-11-05 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,805 | 75,182 | ||
| 2026-09-08 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $4.30 | $17K | 166,844 |
| 2026-09-08 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −8,000 | $21.57 | $173K | 158,844 |
| 2026-09-08 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 78,987 | ||
| 2026-08-13 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +30,000 | $4.30 | $129K | 192,844 |
| 2026-08-13 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −30,000 | $20.26 | $608K | 162,844 |
| 2026-08-13 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 82,987 | ||
| 2026-07-06 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $4.30 | $17K | 170,844 |
| 2026-07-06 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −8,000 | $17.82 | $143K | 162,844 |
| 2026-07-06 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 112,987 | ||
| 2026-05-05 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $4.30 | $17K | 174,844 |
| 2026-05-05 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −7,800 | $14.60 | $114K | 167,044 |
| 2026-05-05 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −200 | $15.58 | $3K | 166,844 |
| 2026-05-05 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 116,987 | ||
| 2026-03-05 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $4.30 | $17K | 178,844 |
| 2026-03-05 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −8,000 | $15.68 | $125K | 170,844 |
| 2026-03-05 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 120,987 | ||
| 2026-02-25 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −1,780 | $14.14 | $25K | 174,844 |
Page 1 of 6 · 105 trades